Absolute cardiovascular risk: The basis for deciding to treat

被引:4
作者
Alderman, MH
机构
[1] Albert Einstein college of Medicine, Montefiore Medical Center, Bronx, NY
关键词
relative risk; absolute risk; blood pressure; hypotensive therapy;
D O I
10.1159/000168997
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
It has been convincingly demonstrated that raised blood pressure is a risk factor for cardiovascular disease and that its reduction saves lives. It seems logical to suggest that the whole population's blood pressure distribution should be displaced downwards, since the reduction of blood pressure by only a few millimeters of mercury, if easily and safely achieved, would produce more disease prevention than could be attained by any other conceivable clinical strategy. Physicians already have powerful tools to lower blood pressure in individual patients, but must make challenging decisions as to when and how to use them. Blood pressure level is a reflection of relative risk and one of many risk factors that determine absolute risk. Reduction of blood pressure therefore does not cure cardiovascular disease, but reduces the risk of developing disease. The need for hypotensive therapy should be determined by absolute risk and the opportunity for successful prevention, rather than by a threshold level of blood pressure. The task of the physician is to assist the patient in assessing the balance between the potential for benefit and the burden of intervention, and to provide the best possible care to implement the therapeutic choice that is made.
引用
收藏
页码:182 / 189
页数:8
相关论文
共 40 条
[1]
TREATMENT-INDUCED BLOOD-PRESSURE REDUCTION AND THE RISK OF MYOCARDIAL-INFARCTION [J].
ALDERMAN, MH ;
OOI, WL ;
MADHAVAN, S ;
COHEN, H .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 262 (07) :920-924
[2]
MANAGEMENT OF THE HYPERTENSIVE PATIENT - A CONTINUING DILEMMA [J].
ALDERMAN, MH ;
MADHAVAN, S .
HYPERTENSION, 1981, 3 (02) :192-197
[3]
ASSOCIATION OF THE RENIN SODIUM PROFILE WITH THE RISK OF MYOCARDIAL-INFARCTION IN PATIENTS WITH HYPERTENSION [J].
ALDERMAN, MH ;
MADHAVAN, S ;
OOI, WL ;
COHEN, H ;
SEALEY, JE ;
LARAGH, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (16) :1098-1104
[4]
LABELING OF HYPERTENSIVES - A REVIEW OF THE DATA [J].
ALDERMAN, MH ;
LAMPORT, B .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1990, 43 (02) :195-200
[5]
ALDERMAN MH, 1982, CARDIOLOGY, V1, P229
[6]
AN UPDATED CORONARY RISK PROFILE - A STATEMENT FOR HEALTH-PROFESSIONALS [J].
ANDERSON, KM ;
WILSON, PWF ;
ODELL, PM ;
KANNEL, WB .
CIRCULATION, 1991, 83 (01) :356-362
[7]
[Anonymous], 1991, JAMA, V265, P3255
[8]
[Anonymous], 1980, LANCET, V1, P1261
[9]
[Anonymous], 1970, JAMA, V213, P1143
[10]
BLOOD-PRESSURE, STROKE, AND CORONARY HEART-DISEASE .2. SHORT-TERM REDUCTIONS IN BLOOD-PRESSURE - OVERVIEW OF RANDOMIZED DRUG TRIALS IN THEIR EPIDEMIOLOGIC CONTEXT [J].
COLLINS, R ;
PETO, R ;
MACMAHON, S ;
HEBERT, P ;
FIEBACH, NH ;
EBERLEIN, KA ;
GODWIN, J ;
QIZILBASH, N ;
TAYLOR, JO ;
HENNEKENS, CH .
LANCET, 1990, 335 (8693) :827-838